![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07H 19/14 | |
A61K 31/7064 | |||
A61P 31/14 |
(11) | Number of the document | 1707571 |
(13) | Kind of document | T |
(96) | European patent application number | 06076021.2 |
Date of filing the European patent application | 2002-01-18 | |
(97) | Date of publication of the European application | 2006-10-04 |
(45) | Date of publication and mention of the grant of the patent | 2011-09-28 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
263313 P | 2001-01-22 | US | |
282069 P | 2001-04-06 | US | |
299320 P | 2001-06-19 | US | |
344528 P | 2001-10-25 | US |
(72) |
Carroll, Steven S., US
Maccoss, Malcolm, US
Olsen, David B., US
Bhat, Balkrishen, US
Bhat, Neelima, US
Cook, Philip Dan, US
Eldrup, Anne B., US
Prakash, Thazha P., US
Prhavc, Marija, US
Song, Quanlai, US
|
(73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
Isis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA 92010, US |
(54) | Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |